Advertisment

Ezogabine (Oral Route)

Ezogabine (Oral Route): A comprehensive guide to controlling seizures and treating epilepsy. Learn about the effectiveness and safety of this anticonvulsant medication.

author-image
Medriva Correspondents
Updated On
New Update
NULL
Advertisment

Ezogabine (Oral Route): A Comprehensive Guide to Treatment for Epilepsy

Advertisment

Ezogabine, sold under the brand name Potiga, is an anticonvulsant medication used to control partial seizures in the treatment of epilepsy. It is a long-acting treatment which is taken on a daily basis to maintain continuously controlled seizures. Across the globe, it is known to be more effective and less likely to produce other unwanted side effects than other anti-epileptic drugs.

Description and Brand Names

Ezogabine (Oral Route) is the trade name for Potiga, a brand-name drug developed and made available by GlaxoSmithKline. In the United States, Potiga is the only approved version of Ezogabine (Oral Route), although there are generic versions of Ezogabine also available in other countries.

Advertisment

Dosage forms and Strengths

Potiga is available in tablets of 25mg, 100mg, and 200mg. The usual dosage for controlling seizures is one 100mg tablet at bedtime, or two 100mg tablets at the same time for severe seizures. The total daily dosage is not to exceed 200mg.

Uses

Advertisment

Ezogabine (Oral Route) is a long-acting anticonvulsant medication used to control partial seizures in treatment of epilepsy. It works by suppressing the seizure activity in the brain and has been effective in preventing seizures when used consistently over a long period of time.

Side effects

The most common side effects of Ezogabine (Oral Route) are abdominal pain, dizziness, nausea and drowsiness. Other potential side effects include headache, increased sweating, joint pain, muscle pain, memory problems, difficulty sleeping and seizures.

Advertisment

Warnings and Precautions

Ezogabine (Oral Route) should be taken as directed by a physician and all medication should be kept away from children and pets. When discontinuing the use of Ezogabine (Oral Route), it is important to slowly reduce the dosage as advised by a doctor to prevent potential withdrawal symptoms. This drug may cause a decrease in fertility in both men and women, and should not be taken during pregnancy or lactation. It is very important to notify all healthcare providers that you are taking Ezogabine (Oral Route) as it may cause impaired alertness and reactions.

Conclusion

Overall, Ezogabine (Oral Route) is an effective anticonvulsant medication used to control partial seizures in treatment of epilepsy. When taken as suggested by a doctor, it is relatively safe and effective for long-term use. It is important to inform all healthcare providers that you are taking this medication as it may impair alertness and reactivity.

Advertisment
Chat with Dr. Medriva !